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A simple and rapid filter radioimmunoassay method can be used to serotype meningococcal strains on a large
scale. The technique consists of simultaneous inoculation of 96 strains on nitrocellulose filters. The resulting
colonies can be processed in situ, by extraction and fixation, incubation with antibodies and 1251-labeled protein
A, and, finally, autoradiography. Processing many filters simultaneously, one person can serotype thousands of
meningococci in a week. Multiple filters with identical strain patterns can be stored after the fixation step for
future screening. The use of monoclonal antibodies is essential; polyclonal antisera, even after extensive
absorption, were not specific in this assay. When results from filter radioimmunoassay and Ouchterlony
microprecipitation were compared for the serotyping of 201 Neisseria meningitidis strains for serotypes 2a and
2b, filter radioimmunoassay was sufficiently sensitive and specific to be useful in mass screening.
In addition to serogrouping on the basis of capsular
polysaccharides, serotyping based on outer membrane pro-
teins (OMPs) supplies useful information about the spread of
virulent meningococcal strains (7, 9). Among the 15 sero-
types described by Frasch (4), serotype 2 has been found
frequently among isolates from patients with meningococcal
disease but infrequently among isolates from carriers, indi-
cating an association with virulence (1, 3, 4, 7, 9, 11, 12, 16).
Serotype 2 has been subdivided into three subtypes: 2a, 2b,
and 2c, which appear to have different distributions among
the serogroups (16).
Current serotyping systems are complicated by the in-
volvement of different molecules (different OMPs, lipopoly-
saccharides), some of which are highly variable (13, 15, 17,
19). To overcome these problems, Frasch et al. recently
proposed a new nomenclature for designation of serotypes
(C. E. Frasch, W. D. Zollinger, and J. T. Poolman, submit-
ted for publication) based on the recognition of five classes
of OMPs which differ in molecular weight and in degree of
variability. The principal protein serotypes, including class-
es 2 and 3 OMPs (molecular weights, 37,000 to 39,000 and
40,000 to 42,000, respectively), that are stably expressed by
the meningococcus are those most suitable for use in epide-
miological studies. To conform with this classification, sero-
typing results obtained in the past must be reevaluated to
confirm the typing and to permit comparison with other
studies. A method for large-scale serotyping, using well-
characterized antisera, is very helpful-not only for retro-
spective screening of collections of meningococci for the
presence of the now well-characterized serotypes, but also
for establishing the occurrence of newly identified serotypes
in the future.
Most of the serotyping methods in common use are
laborious and not suitable for testing large numbers of strains
(2, 5, 6, 8, 12, 19). Therefore, we have adapted and modified
the radioimmunological screening method developed by
Henning et al. (10) so as to apply it in mass serotyping. This
filter radioimmunoassay (FRIA) was used with monoclonal
antibodies directed against serotypes 2a and 2b to test 201
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Neisseria meningitidis strains, and the results were com-
pared with those obtained from immunoprecipitation (16).
(A preliminary report of the FRIA technique has been
published as an abstract [S. de Marie, J. H. J. Hoeijmakers,
J. T. Poolman, and H. C. Zanen, Antonie van Leeuwenhoek
J. Microbiol. Serol. 47:470-472].)
MATERIALS AND METHODS
Strains. All strains of N. meningitidis came from the
collection of the Netherlands Reference Laboratory for
Bacterial Meningitis (comprising nearly 3,500 meningococ-
cal strains collected since 1959) and had been stored at
-70°C in a peptone broth containing 15% glycerol. A total of
201 strains, located between 1966 and 1978 from 167 patients
with systemic meningococcal infection and from 34 asymp-
tomatic carriers, were used to determine the reliability of
serotyping by the FRIA. The 201 strains were selected on
the basis of availability of Ouchterlony immunoprecipitation
data from earlier studies (15, 16), which would allow com-
parison with FRIA for serotyping. Serogrouping by aggluti-
nation and microprecipitation was performed as previously
described (16). These 201 well-characterized strains were
not handled separately, but were included in the screening of
the entire collection of meningococcal strains so that we
could assess the usefulness of the FRIA typing as a large-
scale procedure. In this way, each run of 96 samples
included some whose typing could then be checked against
that obtained by Ouchterlony immunoprecipitation.
FRIA. (i) Filter cultures. Glycerol-peptone broth suspen-
sions of strains were transferred to 96-well microtiter plates.
With a multipoint inoculator (Denley A 400), these were then
inoculated in the same pattern onto nitrocellulose filters
(Millipore HAWP), which were placed on top of Mueller-
Hinton agar plates supplemented with 1% (vol/vol) yeast
extract. The filters were 8.5 by 12.5 cm; the agar plates were
14 by 14 cm. The sterile filters were placed for a few minutes
on a fresh agar plate to wet them before inoculation. The cell
suspensions in each microtiter well were sufficient to inocu-
late 20 filters; suspensions containing between 104 and 106
bacteria per ml resulted in adequate growth. The bacteria
were allowed to grow on the filters for 6 to 10 h at 37°C in 5%
CO2. No differences were observed between growth on
filters and on agar plates. The replica filters, containing
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FIG. 1. FRIA, using polyclonal and monoclonal anti-2a. (a) Auto-
radiogram of one filter culture containing 96 meningococcal strains
after incubation with polyclonal anti-2a. The positions of the strains
are indicated by 1 through 12 horizontally and A through H
vertically; (b) autoradiogram of an identical filter culture after
monoclonal anti-2a.
clearly visible colonies in a pattern identical to that of the
master microtiter plate, were then lifted from the agar and air
dried.
Fixation of the bacteria on the filters and exposure of the
serotype antigens were achieved by a 1-min incubation of the
filters in a phenol-chloroform-heptane mixture (5:5:8 [vol/
vol]), followed by a 15-min wash in chloroform-methanol
(2:1). The filters were then air dried. At this stage, they could
be stored at
-20°C in a sealed box for several years without
significant loss of antigenic activity.
(ii) Radioimmunoassay. To reduce nonspecific binding of
antibody molecules, the filters were floated for 5 h at room
temperature in phosphate-buffered saline (PBS) (140 mM
NaCl, 8 mM Na2HPO4, 2 mM NaH2PO4 [pH 7.4]) containing
3% (wt/vol) bovine serum albumin (fr V, Sigma). The filters
were drip dried and then were incubated with serotype-
specific antibodies by laying each filter on a film of 0.8 ml of
antibody solution (1:30 diluted absorbed polyclonal rabbit
antiserum or a 1:100 dilution of mouse ascites fluid contain-
ing monoclonal antibodies) in a petri dish. The filters were
placed one on top of another, special care being taken to
avoid air bubbles between the filters. The rabbit antiserum
was diluted with PBS (pH 7.4); the monoclonal antibody
solution was diluted with PBS (pH 7.2) containing 0.5% (wt/
vol) bovine serum albumin and 0.2% (vol/vol) Triton X-100.
After overnight incubation at 4°C, unbound antibody mole-
cules were removed by thorough washing in five changes of
PBS supplemented with Nonidet P-40 and Tween 80 (both
0.8% [vol/vol]) over at least 4 h at room temperature.
After a second incubation with 3% bovine serum albumin
in PBS for 1 h at room temperature, 125I-labeled protein A of
Staphylococcus aureus (labeled by the chloramine T method
[14] to a specific activity of 108 dpm/,ug/ was added and
allowed to react with bound antibody molecules for 30 min at
room temperature. Unbound protein A was removed by
thorough washing in an excess of PBS containing Nonidet P-
40 and Tween 80 (both 0.8%) for 20 h, on a shaker and with
at least five changes of rinsing solution. The dried filters
were exposed overnight to Kodak X-Omat R autoradio-
graphic film at -70°C with an Ilford intensifying screen.
Useful FRIA serotyping should result in clearly discernible
spots of serotype-positive bacterial colonies on the X-ray
plan, whereas negative colonies should be hardly visible.
Antisera. Polyclonal anti-2a and anti-2b rabbit antisera
were absorbed thoroughly with heterologous serotype
strains as previously described (16). These antisera were
subsequently absorbed thoroughly by incubation with ly-
sates of heterologous serotype strains to eliminate antibodies
against cell wall or intracellular constituents. Lysates were
obtained by sonication (using a Branson sonifier for 5 min at
70 W with 50% interruption for cooling) of a dense bacterial
suspension. Absorbed antisera were recovered from the
incubation mixture by centrifugation at 100,000 x g and 4°C
for 20 min.
Monoclonal anti-2a and anti-2b immunoglobulin G anti-
bodies were a generous gift of Wendell D. Zollinger (Walter
Reed Army Institute of Research, Washington, D.C.). These
monoclonal antibodies had been characterized by gel im-
munoradioassay (18) as specific for the class 2 proteins of the
respective serotypes.
RESULTS
In FRIA, serotyping for the presence of serotypes 2a and
2b was performed by using two kinds of antibody reagents:
absorbed polyclonal rabbit antisera and monoclonal antibod-
ies. Figure 1 shows autoradiograms of a nitrocellulose filter
after reaction with extensively absorbed polyclonal anti-2a
and with monoclonal anti-2a. When absorbed polyclonal
antisera were used, the FRIA yielded a spectrum of various
densities without sufficient distinction between positive and
negative colonies. In contrast, monoclonal antibodies gave
clearly readable results. Monoclonal anti-2b showed some-
what higher background reactions as compared with mono-
clonal anti-2a, but the results were still easy to interpret.
To determine the sensitivity and specificity of the FRIA
by using monoclonal antibodies, Ouchterlony microprecipi-
tation was used as a reference based on the criterion of
immunological identity. A total of 201 strains had been
tested by Ouchterlony microprecipitation. These same
strains were tested blind in the FRIA, distributed among the
nearly 3,500 meningococcal strains being screened. The
typing results were then extracted for comparison with the
microprecipitation results for detection of both serotypes.
The comparisons are summarized in Tables 1 and 2. FRIA
failed to detect one serotype 2a strain that was positive in
immunoprecipitation, but all of the other 200 strains were
typed the same by both methods. Monoclonal anti-2b gave
more discrepancies with immunoprecipitation (Table 2): 3 of
155 (1.9%) were false-positive, and 5 of 46 (10.9%) were
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false-negative. Variability in growth did not influence the
typing results. Just-visible growth appeared to be adequate
for serotyping.
DISCUSSION
For a reference laboratory such as ours, the development
of a serotyping technique that allows the screening of
thousands of meningococci is desirable for evaluating the
distribution of serotypes over periods of many years. The
FRIA technique described in this article overcomes the
problem of handling each strain individually, as is necessary
in other serotyping methods (2, 5, 6, 8, 12, 19). Each stage of
the FRIA procedure (growth, fixation, exposure of the
serotype antigens, reaction with antibodies, and labeling of
the bound antibodies) is done simultaneously for 96 strains
on one nitrocellulose filter. By simultaneously processing
many filters, it is indeed possible for one person to serotype
thousands of meningococcal strains within a week. Because
multiple filters with identical bacterial patterns can be stored
after the fixation step, large collections of strains can be kept
for future screening for the presence of yet unknown anti-
gens as soon as monoclonal antibodies are available. In view
of the recently proposed revision of classification (Frasch et
al., submitted for publication), this is of special importance
for retrospective study of newly defined serotypes.
The low degree of specificity displayed by extensively
absorbed polyclonal antisera in FRIA might be due to
exposure of cross-reactive immunodeterminants by the fixa-
tion and extraction procedure. Agglutination techniques may
avert such undesirable cross-reactions since they leave the
outer membrane of the bacteria intact; in the case of
immunoprecipitation, isolated outer membranes are used as
antigens. We concluded that both the anti-2a and the anti-2b
polyclonal antisera employed in this study were inadequate
for the FRIA method. However, this problem of nonspecifi-
city was overcome by the use of monoclonal antibodies.
In this study, FRIA was compared with immunoprecipita-
tion as a reference, using the criterion of immunological
identity (16). The FRIA results with anti-2a were excellent
(no false-positive and one false-negative reaction). The re-
sults with anti-2b showed higher failure rates (1.9% false-
positive, 10.9% false-negative), but they were still accept-
able for mass screening purposes. This might indicate that
the immunodeterminant recognized by the monoclonal anti-
2b had been modified by the FRIA procedure in a few cases.
TABLE 1. Comparison of meningococcal serotyping by FRIA
and Ouchterlony immunoprecipitation for serotype 2a
No. of strains found to be:
Anti-2a positive by Anti-2a negative
immunoprecipita- by immunoprecipi- No in
Source of Sero- tion tation No.
meningococci group Positive Negative Positive Negative group
by by by by
FRIA FRIA FRIA FRIA
Patients with A 0 0 0 20 20
disease B 1 0 0 86 87
C 10 0 0 22 32
W-135 15 1 0 2 18
Y 0 0 0 10 10
Carriers B 2 0 0 8 10
C 1 0 0 9 10
W-135 4 0 0 2 6
Y 0 0 0 8 8
TABLE 2. Comparison of meningococcal serotyping by FRIA
and Ouchterlony immunoprecipitation for serotype 2b
No. of strains found to be:
Anti-2b positive by Anti-2b negative
immunoprecipita- by immunoprecipi-
Source of Sero- tion tation No. In
meningococci____________ type_____ sero-meningococci type Positive Negative Positive Negative group
by by by by
FRIA FRIA FRIA FRIA
Patients with A 0 0 0 0 0
disease B 40 5 2 40 87
C 1 0 0 31 32
W-135 0 0 1 17 18
Y 0 0 0 10 10
Carriers B 0 0 0 10 10
C 0 0 0 10 10
W-135 0 0 0 6 6
Y 0 0 0 8 8
Perhaps other monoclonal antibodies against serotype 2b
could be selected to give a high level of specificity and
sensitivity, as did the anti-2a.
The discrepancies between the polyclonal antisera and
monoclonal antibodies revealed in the FRIA again empha-
size the need for characterization and standardization of the
antisera used in serotyping.
In conclusion, the FRIA technique described in this article
is a method very suitable for large-scale (OMP) serotyping of
meningococci, using monoclonal antibodies. The method is
relatively simple, reproducible, and economical with respect
to antibodies, and yields specific and clearly visible results.
The results for more than 3,000 meningococcal strains typed
by monoclonal anti-2a and anti-2b will be described else-
where (S. de Marie, J. T. Poolman, P. Bol, L. Spanjaard,
and H. C. Zanen, submitted for publication).
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